Objective:To explore the influence of gender and age on the measurement of cone beam CT (CBCT) in normal and occluded craniofacial hard tissues for Han nationality in Changsha area.Methods:A total of 80 CBCT data of normal and occluded craniofacial hard tissues for Han nationality in Changsha area were collected,including 40 adults [16 males and 24 females,aged (17.57±1.83) years] and 40 children[16 males and 24 females,age (11.50±1.26) years].Threedimensional cephalometric measurements were carried out by Dolphion Imaging software,and the influence of gender and age was compared.Results:The symmetry of craniofacial hard tissues in male and female in the adults was good (the maximum asymmetric rate R was 6.39％ and the minimum asymmetric rate R was 0.08％).There was no significant differencein the anterior palatal width,palatal width,the upper incisor protrusion distance,the lower incisor protrusion distance,hyoid-mandibular plane,basal epiglottis width,and palatal plane airway width between the males and females (all P＞0.05);while the remaining indicators were significantly higher in males than those in females (all P＜0.05).There was no significant gender difference in angle indicators (all P＞0.05).There were significant differences in the posterior height,the maxillary length,the lower incisor protrusion,and the mandibular plane angle between the adults and the children(all P＜0.05);but the rest of indicators were not significant difference (all P＞0.05).Conclusion:The symmetry of craniofacial hard tissues for Han nationality in Changsha area is good.The gender and age affect the line space measurements but not affect the most of the angle measurements.

To investigate three-dimensional morphological features of temporomandibular joint in skeletal malocclusion Class III with different vertical skeletal facial types.
 Methods: A total of 46 adults with skeletal malocclusion Class III were enrolled and allocated into a normal-angle, a high-angle and a low-angle groups. All patients were undergone cone beam computed tomography (CBCT). Images of temporomandibular joint were reconstructed and analyzed by Invivo 5. Nine measurements relevant to the positions and forms of condyle as well as joint spaces were performed.
 Results: Significant differences were not observed between the 2 sides of each group among skeletal malocclusion Class III (P>0.05). Compared with the high-angle and normal-angle patients, the low-angle patients had larger superior spaces, bigger gradients of the articular tublecle, longer condyle, and larger internal spaces between the condyle and the fossa. Compared with the low-angle and normal-angle patients, the high-angle patients had smaller condylar antero-posterior diameters.
 Conclusion: Class III malocclusion patients with different vertical skeletal patterns have different positions and forms of condyles, which should be paid attention to in clinic.
Adult ; Cone-Beam Computed Tomography ; Face ; diagnostic imaging ; Humans ; Image Processing, Computer-Assisted ; Malocclusion, Angle Class III ; diagnostic imaging ; Mandibular Condyle ; diagnostic imaging ; Temporomandibular Joint ; diagnostic imaging

OBJECTIVETo compare the clinical efficacy and safety among different chemotherapeutic regimens in treatment of refractory/relapsed acute myeloid leukemia (AML).

METHODSThe clinical data of 67 refractory/relapsed AML patients enrolled from September 2008 to April 2013 were collected. The differences of clinical outcome and adverse events among the patients treated with decitabine combined with DAG regimen, CAG regimen or "3+7" regimen were analyzed.

RESULTSAmong 19 patients in decitabine treatment group, 5 (26.3%) achieved complete remission (CR), 4 (21.1%) partial remission (PR), with overall response rate (ORR) of 47.4 %. Of 26 patients in CAG regimen group, 8 (30.8%) achieved CR, 1 (3.8%) PR, with ORR of 34.6%. Of 22 patients in "3+7" regimen group, 4 (18.2%) achieved CR, with ORR of 18.2%. The ORR of decitabine group was significantly higher than that of "3+7" group (P<0.05). However, no significant difference of ORR was observed among the three groups (P>0.05). It was interesting to note that in decitabine group, the marrow blast counts were lower in CR patients compared with those in non-CR patients (P<0.05), while this was not found in "3+7" group (P>0.05) and CAG regimen group (P>0.05). Adverse events in the three groups were similar, mainly including myelosuppression, pulmonary infection, nausea, vomiting and liver dysfunction, and could be well tolerated. Followed- up to September 2013, the median overall survival (OS) of decitabine group, CAG regimen group and "3+7" group after relapse was 7.5, 4 and 3 months, respectively (P>0.05), while significant difference was obtained between decitabine group and "3+7" regimen group (P<0.05).

CONCLUSIONDecitabine combined with DAG regimen is effective and well tolerated in refractory/relapsed AML patients who were unsuitable for intensive chemotherapy and hematopoietic stem cell transplantation, and the patients with low marrow blast counts are more suitable for the application of decitabine combined with DAG regimen.

Adult ; Aged ; Antineoplastic Combined Chemotherapy Protocols ; therapeutic use ; Azacitidine ; administration & dosage ; analogs & derivatives ; Female ; Humans ; Leukemia, Myeloid, Acute ; drug therapy ; Male ; Middle Aged ; Neoplasm Recurrence, Local ; Retrospective Studies ; Treatment Outcome ; Young Adult